TXNDC12 was found to have the ability to promote cell migration in cervical cancer cell line and tubule formation in endothelial cells, which can help to give new directions for the treatment of patients with recurrent or refractory cervical cancer in clinic. This evidence concerns the gene TXNDC12 and cervical carcinoma.